HARP Harpoon Therapeutics Inc: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik harpoontx.com (HARP)

The impeccable reputation of Harpoon Therapeutics (HARP) is confirmed by institutional confidence following a deal with a pharma giant. The company's technological advantage lies in the creation of TriTAC trispecific antibodies for the sustained destruction of tumors. The enterprise value-to-revenue ratio visualizes the dynamics of market asset revaluation, where determines the current value of the metric. Business revenues are based on partnership payments and advances from large corporations.

Nilai perusahaan marang pendapatan: Harpoon Therapeutics Inc (HARP) kanggo 04.07.2022 - 20.11.2026

harpoontx.com - rincian analitis lan metrik utama (HARP)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Harpoon Therapeutics HARP
Sampel barang Harpoon Therapeutics

This indicator compares the total enterprise value, including debt and cash, against annual sales to determine the market premium for future growth. By analyzing the business valuation via EV/Sales, an investor can see how the market capitalizes the potential of Harpoon Therapeutics (HARP) innovative antibodies in combating tumors, forming a long-term consensus between technological risk and the fundamental value of assets.

Analisis pesaing Harpoon Therapeutics

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|MiNK Therapeutics Inc. - Nilai perusahaan marang pendapatan|werewolftx.com (HOWL) - Multiplikator nilai perusahaan marang pendapatan|Immix Biopharma Inc. - Multiplikator EV/Sales|ALXO - Multiplikator EV/Sales|CUE: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PDSB|Rasio nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales LIMN|Multiplikator EV/Sales Lava Tx (LVTX)|Multiplikator EV/Sales NXTC (NextCure Corporation)|Nilai bisnis marang pendapatan LPTX|INTS - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Sensei Biotherapeutics Inc SNSE|TOVX: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Gritstone Bio (GRTS)|KA (Kineta Corp) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan NEXI (NexImmune Corp)|Multiplikator EV/Sales TSBX|VCNX (Vaccinex, Inc.) - Nilai bisnis marang pendapatan